ReviewFrontiers in pharmacology2022

Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305.

Jingcao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.